Cantor Fitzgerald
Cantor Fitzgerald is a leading brokerage service for Wall Street's fixed income inter-dealer community. Cantor is a recognized leader in the specialized areas of equity and fixed income capital markets, offering an impressive array of products and services to more than 5000 institutional clients around the world.
Cantor suffered a devastating loss on September 11, 2001, when the World Trade Center terrorist attacks claimed the lives of 658 of the company's 960 New York-based employees.
Howard W. Lutnick is the company's Chairman and CEO.
-
Companies with NDRs 12/10
-
Provention Bio to Present at Upcoming Virtual Investor Conferences
-
Provention Bio Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Provention Bio Inc. (PRVB) Prices 6.6M Share Common Offering at $14.50/Sh
-
Provention Bio Announces Pricing of $95.7 Million Public Offering of Common Stock
-
Provention Bio Inc. (PRVB) Announces Proposed 5.5M Share Common Offering
-
Provention Bio Announces Proposed Public Offering of Common Stock
-
UPDATE: Cantor Fitzgerald Starts Provention Bio Inc. (PRVB) at Overweight; Sees Large Opportunity in Type 1 Diabetes
-
Provention Bio Inc. (PRVB) Prices 5M Share Common Offering at $8/Sh
-
Provention Bio Announces Pricing of $40 Million Public Offering of Common Stock
-
Provention Bio Inc. (PRVB) Plans Public Offering of Common Stock
-
Provention Bio Announces Proposed Public Offering of Common Stock
